Nucl Med Mol Imaging.
2021 Oct;55(5):203-209. 10.1007/s13139-021-00703-9.
KSNM60 in Non-thyroidal Radionuclide Therapy: Leaping into the Future
- Affiliations
-
- 1Department of Nuclear Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences (KIRAMS), Seoul, South Korea
- 2Department of Nuclear Medicine, Institute of Wonkwang Medical Science, Wonkwang University School of Medicine, Iksan, Jeollabuk-do, South Korea
- 3Department of Nuclear Medicine, Research Institute of Clinical Medicine of Jeonbuk National University and Biomedical Research Institute of Jeonbuk National University Hospital, 20, Geonji-ro, Duckjin-gu, Jeonju-si, Jeollabuk-do 561-803, South Korea
- KMID: 2521458
- DOI: http://doi.org/10.1007/s13139-021-00703-9
Abstract
- This year, the Korean Society of Nuclear Medicine (KSNM) is celebrating its 60th anniversary. Treatment, as well as diagnosis, has played a very important role in the development of nuclear medicine. Since I-131 was used for thyroid therapy in 1959, other radionuclide therapy is still being used, and attempts to use new radionuclide are increasing. In this review, we briefly summarize and introduce the therapies such as radioimmunotherapy, transarterial radioembolization, radionuclide therapy for neuroendocrine tumors, peptide receptor radionuclide therapy, control of metastatic bone pain, radiation synovectomy, radionuclide brachytherapy, alpha particle therapy, and boron neutron capture therapy, which has been being attempted so far in the field of nuclear medicine.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Image-Based Dosimetry of Radionuclide Therapy
- The Clinical Significance of a Minimal Extra-thyroidal Extension of Papillary Thyroid Cancer for the Recurrence of Regional Cervical Lymph Nodes
- Monitoring Gene Therapy by Radionuclide Approaches
- Internal Radiation Dosimetry in Radionuclide Therapy
- A Case of Intra-thyroidal Schwannoma Diagnosed by Preoperative Core Needle Biopsy
